Weight gain and metabolic changes during treatment with antipsychotics and antidepressants

Neuroscience

• 5-HT2C Receptor 33%
• Adenosine Monophosphate 33%
• Adipokine 33%
• Antidepressant 100%
• Cannabinoid Receptor 33%
• Clozapine 100%
• Ghrelin 33%
• Leptin 66%
• Melanocortin 4 Receptor 33%
• Metabolic Disorder 33%
• Metabolic Pathway 100%
• Mirtazapine 33%
• Muscarinic M3 Receptor 33%
• Neuropeptide Y Receptor 33%
• Olanzapine 100%
• Protein Kinases 33%
• Psychopharmacological Treatment 33%
• Tricyclic Antidepressant 33%
• Tumor Necrosis Factor Alpha 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Adenosine Phosphate 33%
• Adipocytokine 33%
• Antidepressant 100%
• Cannabinoid Receptor 33%
• Clozapine 100%
• Cytokine 33%
• Ghrelin 33%
• Leptin 66%
• Melanocortin 4 Receptor 33%
• Metabolic Disorder 33%
• Mirtazapine 33%
• Muscarinic M3 Receptor 33%
• Neuropeptide Y Receptor 33%
• Olanzapine 100%
• Protein Kinase 33%
• Serotonin 2C Receptor 33%
• Side Effect 33%
• Tricyclic Antidepressant 33%
• Tumor Necrosis Factor 33%